Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Exploiting receptor distribution for therapeutic advantage Targeting specific pathologies: Glaucoma primarily ganglion cell disease, choose peptides binding receptors abundant on those cells (Cerebrolysin for TrkB activation)
eNOS protein expression in wound granulation tissue (Western blot: eNOS/GAPDH ratio) is elevated +4452% vs vehicle at day 5
Combination peptide therapy is off-label and has not been studied at scale in controlled clinical trials
But the medication alone does not produce optimal results
US$ 28.83
US$ 28.89
US$ 26.18
US$ 22.50
US$ 24.37
US$ 28.01
